How Patients Guide Our Work

At Sarepta, our work extends beyond the research and development of medicines.  We’re also committed to engaging with and supporting the rare disease communities that we serve by providing patients and their families educational resources and information through advocacy and educational programs.

Our Patient Affairs team understands the value of direct conversation and engagement with advocates and members of rare disease communities around the world. Each day, the team strives to represent the many voices of the patient communities we serve.

Hear from Wendy Erler, senior vice president of Patient Affairs, as she reflects on how Sarepta’s unwavering commitment to a patient-first approach has influenced her leadership and shaped the work of her team. She shares how Patient Affairs ensures that the patient voice is meaningfully integrated from the earliest stages of drug development through to access, driving decisions that truly reflect the needs and experiences of the patient community.

Community Communications

Here we share updates with the community about relevant events and topics.

If you have other questions or topics you'd like to see addressed, please contact [email protected]

Meet Sarepta’s Patient Affairs Team

Wendy Erler
Wendy Erler, MBA
Senior Vice President, Patient Affairs
lamarca
Nicole LaMarca, DNP, MSN, CPNP
Senior Director, Patient Affairs
Rachita Chaudhury-Floros
Rachita Chaudhury-Floros
Associate Director, Patient Affairs
Monique
Monique Dabbous, PhD, MSc
Associate Director, Patient Affairs
Katherine Sinars
Katherine Sinars
Senior Specialist, Patient Affairs
Rachael Titus
Rachael Titus
Senior Specialist, Patient Affairs

Connecting With Communities

Each member of our Patient Affairs team brings passion, energy, and a deep commitment to their work every day. 

To connect with a member of our Patient Affairs team, please email [email protected]

Learn More About Each of Our Therapeutic Areas

Duchenne muscular dystrophy

Ana living with LGMD

Limb-girdle muscular dystrophy

route 79

Route 79, The Duchenne Scholarship Program

Route 79, The Duchenne Scholarship Program, was created to support the post–secondary educational goals of students living with Duchenne. The scholarship is named after the 79 exons in the dystrophin gene impacted with Duchenne. 

Learn more about Route 79

Connect With Us

Whether you have been diagnosed with one of the disease areas that we support, or you are a representative of a patient advocacy organization, we look forward to connecting with you.

Use our contact us form to connect with the Sarepta Patient Affairs team.

Contact Patient Affairs Team